Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update: This manuscript has been produced under the auspices of the Committee of National Societies (CNS) and the Committee of Scientific Advisors (CSA) of the International Osteoporosis Foundation (IOF)

Osvaldo Daniel Messina, Maritza Vidal*, Jorge A.Morales Torres, Luis Fernando Vidal, Constanza Arguissain, Rosa María Pereira, Patricia Clark, Sonia Cerdas Perez, Claudia Campusano, Marise Lazaretti-Castro, Cristiano Zerbini, Juan J. Scali, Lucia Mendez Sanchez, Maria L. Peralta-Pedrero, Andrea Cavallo, Francisco J. Valdivia Ibarra, Talina Hernandez Pérez

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update: This manuscript has been produced under the auspices of the Committee of National Societies (CNS) and the Committee of Scientific Advisors (CSA) of the International Osteoporosis Foundation (IOF)'. Together they form a unique fingerprint.

Medicine & Life Sciences